ISC030-R3 3 ml ready-to-use (RTU)
ISC030-R7 7 ml ready-to-use (RTU)
ISC030-C1 1 ml concentrated
CD30, a 120-kDa transmembrane glycoprotein belonging to the tumor necrosis factor (TNF) receptor superfamily, normally is expressed by a subset (15–20%) of CD3+ T cells after activation by a variety of stimuli. Its expression is stimulated by interleukin (IL)-4 during lineage commitment of human naïve T cells and is augmented by the presence of CD28 costimulatory signals. CD30 appears to have an important immunoregulatory role in normal T cell development. Within the thymus, CD30L is highly expressed on medullary thymic epithelial cells and on Hassal’s corpuscles.
The stated primary antibody is suitable for immunohistochemical staining of FFPE tissue sections based on specific antigen-antibody reaction. Using a detection system linked to HRP or alkaline phosphatase the antigen visualization is performed via specific binding of the primary antibody. Secondary antibody is binding to the primary antibody, and the enzyme complex labels this complex. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. Each step is incubated for a precise time and temperature and requires interposed washing steps. The specimen may then be counterstained. Results are interpreted using a light microscope.
The immunostaining procedure causes a colored reaction product to precipitate at the antigen sites localized by the primary antibody.
Cellular localization: Cell membrane/ cytoplasm.
A qualified pathologist experienced in immunohistochemistry procedures must evaluate positive and negative tissue controls before interpreting patient specimens.
Positive staining intensity should be assessed within the context of any background staining of the negative reagent control.
Note: A negative result means that the antigen in question was not detected, but not that the antigen is not present in the cells/tissues tested. An antibody panel may be used to support the results in some circumstances. Additionally, the morphology of each tissue sample should be examined utilizing a hematoxylin and eosin stained section. A qualified pathologist must interpret the patient’s morphologic findings and pertinent clinical data.
| Primary antibody | CD30 |
| Host | Mouse |
| Subclass | IgG |
| Clone | ISM080 |
| Species Cross-reactivity | Human. Others-not known |
| Applications | Immunohistochemistry |
| Epitope Retrieval | Heat-induced epitope retrieval |
| Ready-to-use antibody | Prediluted antibody in antibody diluent buffer |
| Recommended working dilution range | 1:50 to 1:100 |
Product label shows the specific lot number.
Prediluted antibody is ready-to-use and optimized for staining. No further dilution, reconstitution, mixing, or titration is needed.
Antibody concentrate is optimized for dilution within dilution range using InSituChem® Antibody Diluent for IHC (Cat. No. D005-50). Indicated dilution range should be considered as recommendation and depends on different facts (tissue, fixation, incubation conditions, etc.). Optimum dilution to be determined in user’s own system.
The following materials may be required for staining but are not provided with the primary antibody.
– Positive and negative controls
– Microscope slides (positively charged) and cover slips
– Water bath
– Humidified chamber
– Staining jars
– Stopwatch
– Xylene or xylene substitute
– Ethanol
– Deionized or distilled water
– Antigen retrieval reagent, e.g. Antigen Enhancer (HIER buffer), Cat. No. D004-500
– Detection system, e.g. IHC Complete Detection system (Goat anti mouse/rabbit HRP, DAB staining), Cat. No. D001-15
– Wash buffer: e.g. IHC Wash Buffer, Cat. No. D003-500
– Tap water/bluing reagent (e.g. ammonia water)
– Light microscope
Store at 2 – 8 °C.
When stored correctly antibody is stable to the expiration date indicated on the vial. Do not use after expiration date.
To ensure proper reagent delivery and stability of the antibody, replace the dispenser cap after every use and immediately place the bottle cool in an upright position.
[1] Tamiolakis D, Papadopoulos N, Lambropoulou M, et al. Ber-H2 (CD30) immunohistochemical staining of human fetal tissues[J]. International Journal of Biological Sciences, 2005, 1(4): 135-140.
[2] Kneile J R, Tan G, Suster S, et al. Expression of CD30 (Ber‐H2) in nasopharyngeal carcinoma, undifferentiated type and lymphoepithelioma‐like carcinoma. A comparison study with anaplastic large cell lymphoma[J]. Histopathology, 2006, 48(7): 855-861.
2024-06-10
Change(s) made: –